Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,721 | -28,123 | -20,331 | 10,485 | -52,881 |
| Depreciation Amortization | 35 | 47 | 60 | 92 | 111 |
| Other Working Capital | -1,605 | 3,407 | 1,606 | -19,088 | -6,907 |
| Other Operating Activity | -472 | 1,847 | 2,457 | 2,995 | 20,944 |
| Operating Cash Flow | $-24,763 | $-22,822 | $-16,208 | $-5,516 | $-38,733 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,212 | -4,111 | 17,448 | -15,250 | 10,167 |
| PPE Investments | -24 | -57 | -23 | -4 | -146 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -1 |
| Sale Of Investment | N/A | N/A | 1,620 | 5,557 | 22,569 |
| Investing Cash Flow | $4,188 | $-4,168 | $19,045 | $-9,697 | $32,589 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 33,830 | 9,189 | 18,456 | 222 |
| Financing Cash Flow | $N/A | $33,830 | $9,189 | $18,456 | $222 |
| Beginning Cash Position | 35,252 | 28,412 | 16,386 | 13,143 | 19,065 |
| End Cash Position | 14,677 | 35,252 | 28,412 | 16,386 | 13,143 |
| Net Cash Flow | $-20,575 | $6,840 | $12,026 | $3,243 | $-5,922 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,763 | -22,822 | -16,208 | -5,516 | -38,733 |
| Capital Expenditure | -24 | -57 | -23 | -4 | -146 |
| Free Cash Flow | -24,787 | -22,879 | -16,231 | -5,520 | -38,879 |